Conference Coverage (Vancouver AIDS Conference)
Genentech HIV Vaccine Safe, But Three Thai Subjects Get HIV
Published in Vaccine Weekly, September 23rd, 1996
None of the infections were caused by the vaccine, which contains only the gp120 envelope protein of HIV-1 clade B strain MN. All of the infections were caused by HIV-1 strains belonging to clade E.
The trial was not designed to test the efficacy of the vaccine, and recipients of the vaccine were not expected to become immune to all strains of HIV.
"Two of the volunteers were infected after [receiving] the second dose and one was infected after the third dose," said Sricharoen Migasena of the Mahidol University Faculty of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (1996-09-23)
More Articles from Vaccine Weekly
- Conference Coverage (Vancouver AIDS Conference)
UN Preparing Sites for HIV Vaccine Trials - Conference Coverage (Vancouver AIDS Conference)
Accept Reality and Test HIV Vaccines Now, U.S. Researcher Urges - Conference Coverage (Vancouver AIDS Conference)
Recovering Thai Drug Users Willing to Test HIV Vaccines - AIDS Therapies
Bluebells, Daffodils Could Hold Key To AIDS Drug - At-Risk Populations (TB)
Study Finds BCG Slightly Better than Prophylaxis for HCWs - Breast Cancer
Cancer Vaccine Tested in Portland - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
